RALEIGH, N.C., Feb. 27 /PRNewswire-FirstCall/ -- DARA BioSciences(TM) (Nasdaq: DARA) announced today the appointment of Haywood D. Cochrane, Jr. to the Board of Directors. Mr. Cochrane was appointed to fill a Board vacancy and will serve on the Company's Audit and Compensation Committees. The appointment was effective February 21, 2008.
In making the announcement DARA's Board Chairman, Richard Franco, Sr., commented, "We are pleased that Haywood has joined us as a Director. His vast knowledge and successful experience in the healthcare industry will further strengthen DARA's already skilled Board."
Mr. Cochrane is currently Vice Chairman and a Director of I-trax, Inc. (Amex: DMX), a publicly traded, total population health management and productivity company. Mr. Cochrane has previously served as a Director of seven other publicly-traded companies.
About DARA BioSciences, Inc.
DARA BioSciences(TM), Inc. ("DARA") is a Raleigh, North Carolina-based
development-stage pharmaceutical company that acquires promising
therapeutic molecules and medical technologies directly or through
investment in established companies. DARA focuses its therapeutic
development efforts on small molecules from late preclinical development
through phase 2 clinical trials. DARA is developing a portfolio of
therapeutic candidates for neuropathic pain, metabolic diseases including
type 2 diabetes, dyslipidemia and dermatological disorders. DARA has
licensed promising drug development candidates from Kirin Pharmaceuticals
|SOURCE DARA BioSciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved